HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Therapeutic alternatives in complicated nonsurgical pulmonary aspergillomas]

AbstractWe present 2 patients with pulmonary aspergilloma complicated by massive hemoptysis who were not good candidates for surgery and were treated with intracavitary amphotericin B after arterial embolization failed. In spite of the size of the mycetomas, response to treatment was excellent with full regression of the aspergilloma after 3 to 4 weeks; precipitins to Aspergillus fumigatus became negative and the fungus disappeared from transcatheter aspirate samples. Massive hemoptysis was controlled with epsilon-amino-caproic acid instilled by catheter. No complications were observed, the treatment was well tolerated and no recurrence occurred over a follow-up period of 24 and 18 months, respectively. This local treatment is the best therapeutic alternative for patients with pulmonary aspergilloma who are not candidates for surgery.
AuthorsJ Ortiz de Saracho, E Pérez-Rodríguez, J Zapatero, J Sánchez, P Navío, J Flores (Affiliation: Servicio de Neumología, Hospital Ramón y Cajal, Madrid.)
JournalArchivos de bronconeumología (Arch Bronconeumol) Vol. 31 Issue 2 Pg. 83-5 (Feb 1995) ISSN: 0300-2896 [Print] SPAIN
Vernacular TitleAlternativa terapéutica para los aspergilomas pulmonares complicados no quirúrgicos.
PMID7704395 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Amphotericin B
  • 6-Aminocaproic Acid
Topics
  • 6-Aminocaproic Acid (administration & dosage)
  • Amphotericin B (administration & dosage, therapeutic use)
  • Aspergillosis (complications, drug therapy, radiography)
  • Catheterization
  • Drug Tolerance
  • Follow-Up Studies
  • Hemoptysis (drug therapy, etiology)
  • Humans
  • Lung Diseases, Fungal (complications, drug therapy, radiography)
  • Male
  • Middle Aged
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD